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IntroductIon
Hypertension (HT) is defined by the World Health Organisation 
as a persistent raised arterial blood pressure (BP) of over 140/90 mm 
Hg. It is estimated that nearly one billion people have hypertension 
worldwide1 and is one of the main risk factors for heart disease and 
stroke.2 With an increasingly aging population, as well as rise of other 
risk factors such as obesity, HT is an ever-growing medical problem.
A recent systematic review on hypertension reports a worldwide 
prevalence of 37.4% in males and 37.2% in females in established 
market economy countries. The prevalence of HT varies greatly 
between countries, the lowest prevalence being in rural India (M:F- 
3.4:6.8%) and highest in Poland (M:F -68.9:72.5%). 3
One multinational study carried out in the United States(US), 
Canada and six European countries (Germany, Finland, Sweden, 
England, Spain, Italy) reports the age- and sex-adjusted prevalence 
of HT to be 28% in the North American countries and significantly 
higher in the European countries (44%). 4
A study reviewing compliance in the US reported 69% of the 
population to be aware of their HT diagnosis and the compliance rate 
to medication ranged from 53% to 79%. 5 The compliance rates in 
three Central European countries (Austria, Hungary, Slovakia) was 
found to be 53.5%.6 A UK study reported a prevalence of 11.7% for 
the patient cohort  25-79 years and 46% for patients over 65 years. 7 
The Mediterranean country we intend to study is Malta. The 
population of Malta in 2009 was estimated to be 412,970 and is the 
eighth most densely populated country in the world (1,318 persons/
km2).16 As a result of this high population density,92% of Malta is 
urban.17 It has a GDP per capita of 19.248 billion US dollars.18
The EUROSTAT health interview survey conducted in 2008 
shows the prevalence of hypertension in Malta to be 22.1%. It also 
reveals that 17.2% had been previously prescribed medication for 
their hypertension.19
We intend to compare the data from Malta to a suburb of Dar Es 
Salam, Tanzania, named Buza. Tanzania, an east African country, has 
a population of 38,329,000, and an estimated growth rate of 2%. The 
population distribution is uneven, varying from 1 person per sq. km 
to 134 per sq. km, to 1,787 per sq. km in Dar Es Salam. Over 80% of 
the population lives in rural areas.20  GDP per capita stands at 1,416  
US dollars.21
Hypertensive heart disease complications are shown to occur 
more frequently in Africans than in Europeans and North Americans 
and the majority of affected patients are younger. 22 This is a growing 
problem in all African communities23
A study carried out in Tanzania reported a prevalence rate of HT 
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abstract
Introduction: Worldwide prevalence of hypertension (HT) in 
established market economy countries is estimated at 37.4% for 
males and 37.2% for females. 
Aim: To identify the frequency of HT in sample populations 
of Malta and Buza, Tanzania, looking specifically at gender 
differences, the rate of previous diagnosis and compliance to 
medication. 
Methods: A comparative cross-sectional population-based 
survey to calculate the frequency of hypertension of a 
sample of the Maltese population reviewed in 2010 and a 
sample of people reviewed in a primary care medical clinic 
Buza in that same year. Both samples were statistically 
matched and compared.
Results: Frequency of HT in the Maltese sample was 32.8% 
(M:F - 32.8:32.8),  and compliance rate was 48%. The 
frequency of HT in the Buza sample was 48.4% (M:F - 
47.7:48.9)  and the compliance rate was 8%. Frequency of 
stage II and malignant HT were significantly more prevalent 
in the Buza population. The frequency of HT increased with 
age in both populations studied.
Conclusions: Prevalence of examined HT in the Maltese 
sample was higher than the self-reported survey carried 
out in 2008, but still lower than the Buza sample and 
within range of the established market economy countries. 
Education and awareness of HT will increase lifestyle 
changes and further reduce the frequency of HT and 
increase the compliance rates in both populations. 
Hypertension awareness and readily available treatment is a 
much needed public health service. Furthermore, it is cheap, 
easy to offer and significantly improves quality of life.
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in M:F- 30:26.8% in Ilala (urban area), and M:F - 32:31.5% in Shari 
(rural area). In both areas, less than 20% of hypertensive subjects 
were aware of their diagnosis and approximately 10% reported they 
had previously received treatment; less than 1% had controlled HT.24 
Another study carried out in an urban area in Tanzania reported a 
prevalence of 57% for type I HT and 30% for Type II HT.25
A similar trend in the prevalence of hypertension has been 
reported in other East African countries: Addis Ababa, Ethiopia M:F- 
31.5:28.926, Nakuru, Kenya 50.1%, comparable in men and women27  
and Mozambique; M:F - 35.7:31.2%.28 
The aim of this study is to compare the prevalence of 
hypertension of Malta to Buza. We aim to compare the data whilst 
adjusting for age, gender and population size. To date we believe that 
this is the first comparative study to be done between these countries. 
The authors hypothesise that the prevalence of HT will be higher in 
Buza than in Malta due to an overall better quality of life in Malta 
(rank 28) compared to Tanzania (rank 109) on the Quality of Life 
Index scale29 
methods
study desIgn
A comparative cross-sectional population-based survey to 
calculate the frequency of hypertension of a selected sample of the 
Maltese population compared to a sample of people reviewed in 
a primary care medical clinic Buza, Tanzania. Both samples were 
picked from an urban population setting, the latter population being 
of an overall lower socio-economic status.
sample populatIon
The data for the sample of the Maltese islands was part of a 
national pilot study. This was conducted in 2010 as part of the 
European Health Examination Survey Pilot project.  The Finnish lead 
partners developed the survey protocol. The Maltese team followed 
this protocol during the examination.  Examinations were held in a 
Country study  
was carried out
Male 
Prevalence (%)
Female 
Prevalence (%)
India3 2.4 6.8
Girona, Spain8 14.1 16.9
South West of France9 21.0 19.0
Turkey10 31.8 31.6
Morocco11 30.2 37.0
Hellas, Greece12 33.8 28.4
Pavia, Italy13 40.0 19.0
Algeria14 32.7 44.0
San Marino15 44.0 47.0
Poland3 68.9 72.5
Table 1: Prevalence of Hypertension reported in different countries
public clinic in Gwardamangia, Malta and home visits were carried 
out where participants were unable to travel to clinic. 
Using direct standardisation, the selected sample (n=400) was 
representative of the Maltese resident population aged 18 and over 
and selected randomly from an updated population register.  Random 
stratification was conducted by gender, 10-year age group and region 
of residence.
Of the 221 participants, 219 (99.1%) had their blood pressure 
measured (for 2 participants the meeting never went ahead). 111 
(50.7%) of the population were males, whilst 108 (49.3%) were 
females. Demographic data can be seen in table 2. The mean age of 
the population was 46years (range 18-86).
The protocol required that the blood pressure is measured three 
times. The average from the last two blood pressure measurements 
was taken as the final result. Apart from the measured data, 
respondents were asked before the examination if they have ever 
suffered from hypertension and if they were taking any medication 
for hypertension.   
The Buza sample included any patient ≥ 18 years (n=202) who 
attended the clinic for any medical reason between the 19th July and 
6th August 2010.  Satisfactory data (in a few cases BP readings were 
not documented or taken by the clinician for one reason or other) 
was available on 198 patients (98.0%), 160 (85.0%) of whom were 
females and 38 (15%) were males. Demographic data can be seen in 
table 3. The mean age for the population studied was 37.8years. The 
ages ranged from 18 to 88 years.
In the Buza sample, every person attending the clinic had their 
blood pressure assessed by one of the clinicians. This was recorded in 
the patient’s case notes (and repeated twice or more, so as to ensure 
accuracy), and then managed by the doctors working in the clinic.
Every patient attending the clinic had a full history taken by a 
doctor. Apart from the measured data, respondents were asked before 
the examination if they have ever suffered from hypertension and if 
they were taking any medication for hypertension.   
Figure 1: Sample of Maltese population
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data analysIs
All data collected was inputted into Microsoft Excel and 
analysed using SPSS version 19. The Buza and Maltese sample 
were split by age and gender and Fisher’s Exact test was used to see 
how comparable the study populations were. While there were no 
significant differences between the male populations (Malta n=111, 
Buza n= 38, P=0.58 ) there was a significant difference between the 
female populations (Malta n= 108, Buza n=160, p< 0.001 ). Also the 
Buza population had a gender imbalance within their sample i.e. an 
overly high proportion of females; whilst the Maltese sample had a 
higher proportion of persons aged 55-64 years when compared to 
the national population. These sample differences made it difficult to 
compare populations, so direct standardisation was used to calculate 
age-standardised prevalence against the resident Maltese population 
in 2009.  Confidence intervals were then calculated.  
results
prevalence
The age standardised rate of HT in the Maltese population was 
32.8%, 95% confidence intervals 95% +/-5.1% (95% CI). This was 
statistically significantly lower than the age standardised rates of HT 
for the population in Buza i.e. 48.4% (95%CI+/-6.5%). 
The standardised rates for males in Malta (32.9%, 95%CI +/- 
7.8%) were lower than the Buza male sample (47.7%, 95%CI +/- 
16.8%). A similar trend was seen in the female sample; the frequency 
in Malta was 32.9% (95%CI +/- 6.3%) compared to the Buza sample 
48.9% (95% CI +/- 7.6%).
stages of hypertensIon
A blood pressure within normal range was found in 73 cases 
(33.3%) of the Maltese population, which was slightly lower than 
the population studied in Buza (n=69, 34.3%). There was a higher 
proportion of the Maltese population who presented in a pre-
hypertensive stage (n=72, 32.9%) compared to Buza (n=43, 21.7%). 
Stage 1 hypertension was commoner in the Malta sample (n=54, 
24.7%) when compared to the Buza sample (n=25, 12.6%). However, 
there was a markedly higher frequency of stage 2 hypertension 
recorded in the Buza sample (n= 31, 15.7%). 
 
IncIdence and controlled cases
62 cases in the Buza sample (69.7%, CI 95% 60.1 – 74.2%) were 
incident cases. The frequency of new cases was higher than the 
Maltese sample (n=38, 51.1%). 
48 cases were prescribed medication in the Maltese sample; 23 
(47.9%) of these patients had their hypertension controlled (i.e. blood 
pressure < 140/90mmHg). The rate of controlled hypertension was 
significantly higher (P<0.001) than the number of cases in the Buza 
sample (n=2), out of 25 patients meant to be on medication.
Male
% (N)
Female
% (N)
Total
% (N)
Total 50.7 (111) 49.3 (108) 100 (219)
Age <25 9 (10) 8.3 (9) 8.7 (19)
25 – 34 19.8 (22) 16.7 (18) 18.3 (40)
35 – 44 15.3 (17) 13.9 (15) 14.6 (32)
45 – 54 15.3 (17) 18.5 (20) 16.9 (37)
55 – 64 22.5 (25) 24.1 (26) 23.3 (51)
65 – 74 13.5 (15) 12 (13) 12.8 (28)
75+ 4.5 (5) 6.5 (7) 5.5 (12)
Table 2: Overview of age frequency of the Maltese sample 
Male
% (N)
Female
% (N)
Total
% (N)
Total 19.2 (38) 80.8 (160) 100 (198)
Age <25 13.2 (5) 8.8 (14) 9.6 (19)
25 – 34 18.4 (7) 28.1 (45) 26.3 (52)
35 – 44 5.3 (2) 22.5 (36) 19.2 (38)
45 – 54 13.2 (5) 18.1 (29) 17.2 (34)
55 – 64 21.1 (8) 10 (16) 12.1 (24)
65 – 74 23.7 (9) 8.1 (13) 11.1 (22)
75+ 5.3 (2) 4.4 (7) 4.5 (9)
Table 3:  Overview of age frequency of the Buza sample
InclusIon crIterIa
The sample from both populations included any adult ≥ 18 years 
of any gender and social class. Only participants who could give 
informed consent were included in this study.   
exclusIon crIterIa
All patients under the age of 18 years were excluded from our study. 
ethIcal consIderatIons 
Participation in both surveys was against informed consent.  All 
participants were asked to consent to the anthropometric measures 
separately from other components of the examination such that they 
could chose to opt out of specific measures without being excluded 
from the examination. Only participants who were deemed to have 
capacity to consent to the study at that present time were included. 
The final dataset was anonymized and kept confidential using 
password protected datasets.
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dIscussIon 
The prevalence of HT in the Maltese sample was lower (32.8%) than 
the sample studied in Buza (48.5%). However the frequency was higher 
than the self-reported survey (22.5%) carried by the department of 
health in 2008. This result of examined blood pressure is more reliable 
than the self-reported results carried out in 2008. The above result is in 
keeping with the authors’ hypothesis and can probably be explained by 
the substantial difference in the quality of life between the two countries 
(Malta 28th and Tanzania 109th). 
The prevalence in Malta was lower than the average calculated for 
the market economy countries (37.3%) and North Africa Mediterranean 
countries (Algeria and Morocco), similar to the prevalence reported 
in Greece and Turkey but higher than the western European countries 
(Spain and South West France).3 The prevalence in Buza was found to 
be within the range reported in studies (30-57%) carried out previously 
in Tanzania.24,25 The prevalence in Buza was higher than that reported in 
Ethiopia (31%)26 and Mozambique (33.5%)28, but lower than that found 
in Nakuru, Kenya (50.1%).27
No statistically significant difference was found between males and 
females in both population samples. The prevalence of patients suffering 
from Stage 2 Hypertension in Buza (12.6%) was more than double that 
of Malta (5.9%). However the Maltese sample had a higher prevalence 
of patients with Stage 1 Hypertension and Pre-Hypertensive blood 
pressure. Malta also had a higher prevalence rate but a lower incidence 
rate than Buza, highlighting the greater awareness and availability of 
clinics to manage HT in Malta and other developed nations. 
It was also found that in both hypertensive cohorts, the Maltese 
patients had better HT control. This reflects a better compliance rate 
amongst the Maltese population (48% compared to 8% in Buza) which 
may be related to a greater HT awareness amongst the population and 
healthcare professionals in Malta. This could also be a result of more 
widely available health services. Less than a third of the sample in Buza 
were aware that they were suffering from high blood pressure; this is 
comparable to a parallel study (20%) carried out in Ilalia Tanzania.24 
Over 9% of the target population in Buza had malignant hypertension, 
but no cases of malignant hypertension were reported in Malta, further 
substantiating better HT awareness and the availability of services.
It was further observed that in the 35-44 and 45-54 year age groups 
the prevalence of hypertension in women in Buza rose from 33% 
to 66%. One can hypothesise that most probably almost all women 
in menopause were suffering from hypertension. This is further 
substantiated by the increase in frequency of hypertension with age. 
In males this increase in HT was not statistically significant (P = 
0.149) though this could be a result of the small male sample. This 
finding differs from other studies as the rate of HT in males increases 
proportionally with age.30 The trend of proportionally increasing Figure 2: Frequency of hypertension by gender
Malta
N  (%, 95%CI)
Buza
N (%, 95%CI)
Total 219 (100) 198 (100)
Blood pressure within normal range 73 (33.3, 39.5 – 27.1) 68 (34.3, 43.7 – 25.1)
Pre-hypertensive: 120-139/80-89 72 (32.6, 38.8 – 26.4) 43 (21.7, 29.3 – 13.6)
Stage 1 hypertension:140-159 or >90-99 54 (24.4, 30.1 – 18.7) 31 (15.7,  22.8 – 8.6)
Stage 2 hypertension: >160/100 13 (5.9, 9.0 – 2.8) 25 (12.6,  19.1 – 6.1)
Malignant hypertension:>180/110 0 (0) 19 (9.6,  15.4 – 3.8)
Hypertension >130/80 with DM, CHD,MI, CVA, kidney disease 6 (2.7, 4.8 – 0.6) 6 (3,  6.3 – 0.6)
Isolated hypertension:>140 and<90 1 (0.5, 1.4 – 0.4) 6 (3,  6.3 – 0.6)
Table 4: Number of cases in the different stages of hypertension
Malta
N (%)
Buza
N (%)
Total Cases 74 (100) 88 (100)
Incidence 38 (51.4) 62 (69.7)
Prevalence 36 (48.6) 27 (30.3)
Prescribed medication 48 (64.8) 25 (28.4)
No prescribed medication 26 (35.1) 63 (71.6)
Table 5: Comparisons between Malta and Tanzania for incidence and medication
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HT in both sexes by age was found in the Maltese sample. The 
greater frequency of HT in Malta may be a result of Malta’s ageing 
population, with 13% of the population above the age of 65.
strengths and lImItatIons of the study
The results from our study report only examined BP as opposed 
to self-reporting, thus reducing a recall bias.
The population sample in this study did not only include patients 
who were ill but also those who attended the clinic merely for a check 
up, thus reducing the selection bias.
All patients had their BP checked at least twice in keeping with 
recommended standards.
Limitations of this study include a relatively small sample 
size, although direct standardisation was used to account for 
any discrepancies in representation of the target population. A 
longitudinal study with a larger sample size is recommended.
clInIcal ImplIcatIons
In keeping with the human development index, the prevalence 
of HT in the Maltese sample was lower than that found in the Buza 
sample. Further education and awareness campaigns directed to all 
ages of the population on HT prevention strategies would reduce 
prevalence rates in the Maltese population and also improve the HT 
medication compliance rates.
The prevalence of hypertension is expected to rise substantially 
in sub-Saharan Africa, so the authors call for population-based 
studies and registries of the epidemiology of hypertension in the 
African population. The provision of awareness campaigns and more 
clinics available for assessment and management of HT in the health 
services in Tanzania is strongly recommended. As reported in this 
study this cheap provision of service yields quick positive results, thus 
improving the overall quality of life of the people living in Tanzania.
As other HT studies reported in other countries, more than 
half of respondents took action following the receipt of advice.5 The 
authors believe that this simple measure will have a highly positive 
effect on the people living in these countries. 
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Figure 3: Male and female prevalence of hypertension
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